Blood Microbiota Dysbiosis Is Associated with the Onset of Cardiovascular Events in a Large General Population: The D.E.S.I.R. Study

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Amar, Jacques ^a   Lange, Céline ^b   Payros, Gaëlle ^c   Garret, Celine ^c   Chabo, Chantal ^a,c   Lantieri, Olivier ^d   Courtney, Michael ^e   Marre, Michel ^f,g   Charles, Marie Aline ^b   Balkau, Beverley ^b   Burcelin, Rémy ^a,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c Bio Medical Research Federative Institute of Toulouse   (France)

^d IRSA   (France)

^e VAIOMER SAS   (France)

^f BICHAT HOSPITAL   (France)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 16S;

ADULT; AGED; ARTICLE; BACTERIAL FLORA; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM DETECTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSBIOSIS; EUBACTERIUM; FEMALE; GENE SEQUENCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEOBACTERIA; SEQUENCE ANALYSIS;

ADULT; AGE OF ONSET; AGED; BACTERIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; FRANCE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; METAGENOME; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEOBACTERIA; RISK; RNA, RIBOSOMAL, 16S;

BACTERIA (MICROORGANISMS); PROTEOBACTERIA;

EID: 84872871160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054461     Document Type: Article

References (44)

1. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, et al. (2006) Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296: 2939-2946.
2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, et al. (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362: 2155-2165.
3. Blacher J, Evans A, Arveiler D, Amouyel P, Ferrières J, et al. (2004) PRIME Study Group. Residual coronary risk in men aged 50-59 years treated for hypertension and hyperlipidaemia in the population: the PRIME study. J Hypertens 22: 415-423.
4. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, et al. (2009) Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 151: 496-497.
5. Gilbert A, Lion G, (1889) Artérites infectieuses expérimentales. Comptes Rendus Hebdomadaires des Séances et Mémoires de la Société de Biologie 41: 583-584.
6. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH, (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 15: 827-832.
7. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, et al. (2002) AtheroGene Investigators. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105: 15-21.
8. Madjid M, Naghavi M, Litovsky SA, Casscells SW, (2003) Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 108: 2730-6.
9. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, et al. (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351: 2611-2618.
10. Pussinen PJ, Nyyssönen K, Alfthan G, Salonen R, Laukkanen JA, et al. (2005) Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 25: 833-838.
11. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-63.
12. Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, et al. (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 34: 1975-1981.
13. Amar J, Ruidavets JB, Bal Dit Sollier C, Bongard V, Boccalon H, et al. (2003) Soluble CD14 and aortic stiffness in a population-based study. J Hypertens 21: 1869-1877.
14. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, et al. (2005) Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112: 2193-2200.
15. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, et al. (2011) Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 108 Suppl 1: 4592-4598.
16. Amar J, Serino M, Lange C, Chabo C, Iacovoni J, et al. (2011) D.E.S.I.R. Study Group. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54: 3055-3061.
17. Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, et al. (2011) Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A 108: 11548-11553.
18. Greenblum S, Turnbaugh PJ, Borenstein E, (2012) Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A 109: 594-599.
19. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, et al. (2011) High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11: 7.
20. De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, et al. (2010) Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 10: 63.
21. Fumeron F, Aubert R, Siddiq A, Betoulle D, Péan F, et al. (2004) Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group. Diabetes 53: 1150-1157.
22. Coenye T, Vandamme P, (2003) Intragenomic heterogeneity between multiple 16S ribosomal RNA operons in sequenced bacterial genomes. FEMS Microbiol Lett 228: 45-49.
23. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, et al. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346.
24. Marcadet A, O'Connell P, Cohen D (1987) Standardized Southern blot workshop technique. In: Dupont B (ed) Histocompatibilty testing, vol 1. Springer, New York, pp 553-60.
25. Valladares R, Sankar D, Li N, Williams E, Lai KK, et al. (2010) Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats. Plos one 5: e10507.
26. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, et al. (2005) Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111: 576-582.
27. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, et al. (2001) Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103: 45-51.
28. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ, (2000) Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71: 1554-1560.
29. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, et al. (2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113: 929-937.
30. Katz JT, Shannon RP, (2006) Bacteria and coronary atheroma: more fingerprints but no smoking gun. Circulation 113: 920-922.
31. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480-484.
32. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
33. Garrett WS, Gordon JI, Glimcher LH, (2010) Homeostasis and inflammation in the intestine. Cell 140: 859-870.
34. Kinloch AJ, Alzabin S, Brintnell W, Wilson E, Barra L, et al. (2011) Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4-IE-transgenic mice. Arthritis Rheum 63: 3818-3823.
35. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ, (2010) Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol 6: 727-730.
36. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, et al. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179-185.
37. Ogilvie LA, Jones BV, (2012) Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease? Gut 61: 1642-3.
38. Andraws R, Berger JS, Brown DL, (2005) Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 293: 2641-2647.
39. De La Cochetière MF, Durand T, Lepage P, Bourreille A, Galmiche JP, et al. (2005) J Clin Microbiol 43: 5588-5592.
40. Dethlefsen L, Huse S, Sogin ML, Relman DA, (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280.
41. Dethlefsen L, Relman DA, (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108 Suppl 1: 4554-4561.
42. Erridge C, Attina T, Spickett CM, Webb DJ, (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86: 1286-92.
43. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W, (1999) Bacterial endotoxin is an active component of cigarette smoke. Chest 115: 829-835.
44. Bonora E, Targher G, (2012) Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol 9: 372-81.